Meyer D, Piétu G, Fressinaud E, Girma J P
Institut National de la Santé et de la Recherche Médicale, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
Mayo Clin Proc. 1991 May;66(5):516-23. doi: 10.1016/s0025-6196(12)62394-5.
Von Willebrand factor (vWF) is an adhesive, multimeric glycoprotein present in plasma, platelets, and subendothelium, which has two main functions: (1) it serves as a carrier for factor VIII and (2) it plays a crucial role in platelet adhesion to subendothelium, acting as a "bridge" between platelet membrane glycoprotein (GP) Ib and GP IIb/IIIa and subendothelial components such as collagen and heparin. vWF is involved at high shear rates in the initial contact of platelets with the subendothelium, in their subsequent spreading, and in thrombus formation. The three pools of vWF (plasma, platelets, and subendothelium) are necessary for optimal adhesion. Specific fragments of vWF involved in binding to platelets, collagen, heparin, and factor VIII have been mapped by using a series of proteases and well-characterized monoclonal antibodies to distinct epitopes of vWF. Several groups, including ours, have identified at least eight functional domains on the 270-kd subunit that consists of 2,050 amino acids. The importance of the binding domains to GP Ib and to collagen is illustrated by the role of vWF fragment SpIII (amino acids 1 through 1,365) in promoting platelet adhesion to collagen. The role of the vWF-GP Ib axis and of the vWF-GP IIb/IIIa axis in platelet-vessel wall interactions has been demonstrated through the study of patients, monoclonal antibodies, recombinant fragments, and synthetic peptides. We have recently expressed fragments of vWF complementary DNA in Escherichia coli. One of these recombinant fragments, which spans amino acids 449 through 730, binds to platelets in the presence of ristocetin, to collagen, and to heparin and has the property of inhibiting ristocetin-induced platelet agglutination. The second fragment, which spans amino acids 914 through 1,364, binds to collagen.(ABSTRACT TRUNCATED AT 250 WORDS)
血管性血友病因子(vWF)是一种存在于血浆、血小板和内皮下的黏附性多聚体糖蛋白,它有两个主要功能:(1)作为因子VIII的载体;(2)在血小板黏附于内皮下过程中起关键作用,充当血小板膜糖蛋白(GP)Ib与GP IIb/IIIa以及内皮下成分(如胶原蛋白和肝素)之间的“桥梁”。vWF在高剪切速率下参与血小板与内皮下的初始接触、随后的铺展以及血栓形成。vWF的三个池(血浆、血小板和内皮下)对于最佳黏附是必需的。通过使用一系列蛋白酶和针对vWF不同表位的特性明确的单克隆抗体,已确定了vWF与血小板、胶原蛋白、肝素和因子VIII结合所涉及的特定片段。包括我们在内的几个研究小组已在由2050个氨基酸组成的270-kd亚基上鉴定出至少八个功能域。vWF片段SpIII(氨基酸1至1365)在促进血小板与胶原蛋白黏附中的作用说明了结合域对GP Ib和胶原蛋白的重要性。通过对患者、单克隆抗体、重组片段和合成肽的研究,已证实了vWF-GP Ib轴和vWF-GP IIb/IIIa轴在血小板-血管壁相互作用中的作用。我们最近在大肠杆菌中表达了vWF互补DNA片段。其中一个重组片段跨度为氨基酸449至730,在瑞斯托霉素存在的情况下与血小板、胶原蛋白和肝素结合,并具有抑制瑞斯托霉素诱导的血小板凝集的特性。第二个片段跨度为氨基酸914至1364,与胶原蛋白结合。(摘要截短于250字)